Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 12.7% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 786,336 shares of the company’s stock after buying an additional 88,725 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.34% of Dentsply International worth $48,784,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in XRAY. Sumitomo Mitsui Asset Management Company LTD increased its position in shares of Dentsply International by 1.0% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 18,680 shares of the company’s stock worth $1,158,000 after buying an additional 183 shares in the last quarter. Harvey Investment Co. LLC increased its position in shares of Dentsply International by 0.3% in the second quarter. Harvey Investment Co. LLC now owns 190,561 shares of the company’s stock worth $11,822,000 after buying an additional 499 shares in the last quarter. LMR Partners LLP purchased a new position in shares of Dentsply International during the second quarter worth about $856,000. Emerald Advisers Inc. PA increased its position in shares of Dentsply International by 10.6% in the second quarter. Emerald Advisers Inc. PA now owns 114,120 shares of the company’s stock worth $7,080,000 after buying an additional 10,920 shares in the last quarter. Finally, Trillium Asset Management LLC increased its position in shares of Dentsply International by 26.4% in the second quarter. Trillium Asset Management LLC now owns 174,750 shares of the company’s stock worth $10,841,000 after buying an additional 36,520 shares in the last quarter. Hedge funds and other institutional investors own 94.61% of the company’s stock.

Institutional Ownership by Quarter for Dentsply International (NASDAQ:XRAY)

Dentsply International Inc. (NASDAQ:XRAY) traded down 0.63% during mid-day trading on Monday, reaching $58.33. 1,697,584 shares of the company traded hands. The firm’s 50-day moving average is $59.80 and its 200 day moving average is $61.31. Dentsply International Inc. has a 52-week low of $53.43 and a 52-week high of $65.83.

Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.06. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The company earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter last year, the company earned $0.73 earnings per share. Dentsply International’s revenue for the quarter was up 46.4% on a year-over-year basis. Equities analysts predict that Dentsply International Inc. will post $2.76 EPS for the current fiscal year.

The company also recently disclosed a dividend, which was paid on Friday, October 14th. Shareholders of record on Friday, September 30th were given a $0.0775 dividend. The ex-dividend date was Wednesday, September 28th. Dentsply International’s dividend payout ratio (DPR) is 14.49%.

A number of research analysts recently issued reports on the stock. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a research note on Sunday, June 26th. JPMorgan Chase & Co. assumed coverage on shares of Dentsply International in a research note on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 price target for the company. Zacks Investment Research downgraded shares of Dentsply International from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Piper Jaffray Cos. reiterated a “buy” rating on shares of Dentsply International in a research note on Monday, June 27th. Finally, Barrington Research downgraded shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $66.91.

In other news, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the sale, the vice president now owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Maureen J. Macinnis sold 17,650 shares of the firm’s stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $60.61, for a total transaction of $1,069,766.50. Following the sale, the senior vice president now directly owns 19,630 shares of the company’s stock, valued at approximately $1,189,774.30. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.